Schedule 13G ownership disclosure
CHROMOCELL THERAPEUTICS CORP
Security class unavailable · CUSIP: 171126105
Event date: 2024-02-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 384,226
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-24-000449
- Form type
- SC 13G
- Filer
- Benuvia Operations, LLC
- CIK
- CIK 2011242
- Filed
- Mar 01, 2024
- Reporting period
- Feb 21, 2024
- Description
- Schedule 13G beneficial ownership